Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
30.23
-1.81 (-5.65%)
At close: Apr 15, 2025, 4:00 PM
29.97
-0.26 (-0.87%)
Pre-market: Apr 16, 2025, 4:24 AM EDT
Vaxcyte Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Vaxcyte stock have an average target of 136.5, with a low estimate of 90 and a high estimate of 163. The average target predicts an increase of 351.54% from the current stock price of 30.23.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Vaxcyte stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 5 | 5 | 6 | 6 | 6 |
Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Hold | 1 | 1 | 1 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 8 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Needham | Needham | Strong Buy Reiterates $90 | Strong Buy | Reiterates | $90 | +197.72% | Apr 8, 2025 |
Goldman Sachs | Goldman Sachs | Strong Buy Maintains $138 → $100 | Strong Buy | Maintains | $138 → $100 | +230.80% | Apr 1, 2025 |
B of A Securities | B of A Securities | Strong Buy Maintains $157 → $137 | Strong Buy | Maintains | $157 → $137 | +353.19% | Apr 1, 2025 |
Needham | Needham | Strong Buy Maintains $140 → $90 | Strong Buy | Maintains | $140 → $90 | +197.72% | Apr 1, 2025 |
Guggenheim | Guggenheim | Strong Buy Reiterates $160 | Strong Buy | Reiterates | $160 | +429.28% | Mar 12, 2025 |
Financial Forecast
Revenue This Year
n/a
from 2.07B
Revenue Next Year
n/a
EPS This Year
-4.61
from -3.80
EPS Next Year
-4.63
from -4.61
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | n/a | n/a | 346.5M | ||
Avg | n/a | n/a | 93.1M | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -3.64 | -2.51 | -1.96 | ||
Avg | -4.61 | -4.63 | -4.56 | ||
Low | -5.49 | -5.35 | -5.95 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.